Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.
Nasal drug delivery is now emerging as a promising route for the rapid delivery of certain classes of molecules.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback